Protection from COVID-19 without a jab? Trial results of inhaled vaccine show promise
Instead of being poked with a needle, inhaling a little bit of aerosol – that’s how getting vaccinated against the SARS-CoV-2 coronavirus could soon look like.
Stay updated with breaking news from Brian Lichty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Instead of being poked with a needle, inhaling a little bit of aerosol – that’s how getting vaccinated against the SARS-CoV-2 coronavirus could soon look like.
Scientists at McMaster University in Canada have developed an inhaled form of COVID-19 vaccine that can offer broad and long-lasting protection against SARS-CoV-2 variants of concern, a preclinical study has found. The study, published recently in Cell, discusses the immune mechanisms and the benefits of delivering vaccines directly to the respiratory tract rather than by injection.
An inhaled form of COVID-19 vaccine developed by scientists at McMaster University in Canada can provide broad, long-lasting protection against the SARS-CoV-2 variants of concern, a preclinical study has found
McMaster researchers developing vaccine for COVID-19, other viruses by News staff McMaster researchers developing vaccines to fight COVID-19. (Courtesy of McMaster University) A homegrown vaccine candidate may potentially have huge implications for fighting not only the COVID-19 pandemic, but also future ones as well. A first of its kind, specialized facility at McMaster University in Hamilton is developing and producing two vaccines which they say could fight the COVID-19 virus and others that may come up. A release from the university explains that the vaccines differ from the ones currentl...
Do we know how effective vaccines are against the variants? Your COVID-19 questions answered The good news is the coronavirus that causes COVID-19 doesn't seem to mutate as much or as quickly as the influenza virus that causes the flu. Drugmakers are already re-working their vaccines. Social Sharing CBC News · Posted: Feb 23, 2021 4:00 AM ET | Last Updated: March 24 A health-care professional prepares a dose of the Pfizer-BioNTech COVID-19 vaccine for high-risk workers in Melbourne, Australia.(Sandra Sanders/Reuters file photo)